Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 3/2021

01-03-2021 | Endoscopy | Letter to Editor/LED Reply

Reply to: Incidence of Marginal Ulcers After Gastric Bypass Seems to Be Inversely Related to the Duration of Prophylaxis with Proton Pump Inhibitors

Authors: Sandeep Aggarwal, Aditya Baksi, Devanish N. H. Kamtam

Published in: Obesity Surgery | Issue 3/2021

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Baksi A, Kamtam DNH, Aggarwal S, et al. Should surveillance endoscopy be routine after one anastomosis gastric bypass to detect marginal ulcers: initial outcomes in a tertiary referral centre. [published online ahead of print, 2020 July 27]. Obes Surg. 2020; https://​doi.​org/​10.​1007/​s11695-020-04864-y.
2.
Kurlander JE, Rubenstein JH, Richardson CR, et al. Physicians’ perceptions of proton pump inhibitor risks and recommendations to discontinue: a national survey. Am J Gastroenterol. 2020;115(5):689–96.CrossRef
3.
Freedberg DE, Kim LS, Yang Y-X. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017;152(4):706–15.CrossRef
4.
Sanyal AJ, Sugerman HJ, Kellum JM, et al. Stomal complications of gastric bypass: incidence and outcome of therapy. Am J Gastroenterol. 1992;87(9):1165–9.PubMed
5.
Csendes A, Burgos AM, Altuve J, et al. Incidence of marginal ulcer 1 month and 1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 patients with morbid obesity. Obes Surg. 2009;19(2):135–8.CrossRef
6.
D’Hondt MA, Pottel H, Devriendt D, et al. Can a short course of prophylactic low-dose proton pump inhibitor therapy prevent stomal ulceration after laparoscopic Roux-en-Y gastric bypass? Obes Surg. 2010;20(5):595–9.CrossRef
Metadata
Title
Reply to: Incidence of Marginal Ulcers After Gastric Bypass Seems to Be Inversely Related to the Duration of Prophylaxis with Proton Pump Inhibitors
Authors
Sandeep Aggarwal
Aditya Baksi
Devanish N. H. Kamtam
Publication date
01-03-2021
Publisher
Springer US
Published in
Obesity Surgery / Issue 3/2021
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-05051-9

Other articles of this Issue 3/2021

Obesity Surgery 3/2021 Go to the issue

Original Contributions

Effect of Roux-en-Y Gastric Bypass on Lipoprotein Metabolism and Markers of HDL Functionality in Morbid Obese Patients

Original Contributions

Asymptomatic Cholelithiasis and Bariatric Surgery: a Comprehensive Long-Term Analysis of the Risks of Biliary Disease in Patients Undergoing Primary Roux-en-Y Gastric Bypass

Original Contributions

Development and Validation of a Predictive Model of Success in Bariatric Surgery

Original Contributions

Efficacy of Liraglutide to Prevent Weight Regain After Retrieval of an Adjustable Intra-gastric Balloon—a Case-Matched Study

Review

The Application of Enhanced Recovery After Surgery (ERAS) for Patients Undergoing Bariatric Surgery: a Systematic Review and Meta-analysis

Letter to Editor/LED Reply

Authors Response from Letter to the Editor Concerning: Bures C, Benzing C, Marchesini JC, Sobottka WH, Sadowski JA, Marchesini JB, Zorron R. The “Hug” Technique Roux-en-Y Gastric Bypass with Preservation of the Posterior Wrap in Patients with Nissen Fundoplication: a Simple Solution for a Complex Problem